Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Procept BioRobotics Corp (NASDAQ: PRCT) closed at $57.09 in the last session, down -2.01% from day before closing price of $58.26. In other words, the price has decreased by -$2.01 from its previous closing price. On the day, 0.65 million shares were traded. PRCT stock price reached its highest trading level at $58.79 during the session, while it also had its lowest trading level at $56.55.
Ratios:
We take a closer look at PRCT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.01 and its Current Ratio is at 9.07. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’25 when Zadno Reza sold 5,475 shares for $57.06 per share. The transaction valued at 312,404 led to the insider holds 173,070 shares of the business.
Waters Kevin sold 733 shares of PRCT for $41,825 on Mar 18 ’25. The EVP, CFO now owns 107,991 shares after completing the transaction at $57.06 per share. On Mar 18 ’25, another insider, Shiblaq Hisham, who serves as the EVP, Chief Comm. Officer of the company, sold 247 shares for $57.06 each. As a result, the insider received 14,094 and left with 63,133 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 3129599488 and an Enterprise Value of 2878124544. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.94 while its Price-to-Book (P/B) ratio in mrq is 7.77. Its current Enterprise Value per Revenue stands at 12.82 whereas that against EBITDA is -31.496.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.09, which has changed by 0.22642314 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $45.56. The 50-Day Moving Average of the stock is -11.87%, while the 200-Day Moving Average is calculated to be -23.04%.
Shares Statistics:
According to the various share statistics, PRCT traded on average about 940.24K shares per day over the past 3-months and 830920 shares per day over the past 10 days. A total of 54.72M shares are outstanding, with a floating share count of 51.88M. Insiders hold about 5.37% of the company’s shares, while institutions hold 92.18% stake in the company. Shares short for PRCT as of 1741910400 were 5829532 with a Short Ratio of 6.20, compared to 1739491200 on 5684573. Therefore, it implies a Short% of Shares Outstanding of 5829532 and a Short% of Float of 14.32.
